Trial intelligence / Profile preview

Intravenous lidocaine dose comparison for prevention of cough and sore throat after general anesthesia

TCTR20200325003Phase 2Enrolling by invitation

Sponsor
Phramongkutklao Hospital
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lidocaine in cough, Post-extubation sore throat (POST), sponsored by Phramongkutklao Hospital. Started Feb 2020; status: enrolling by invitation.

02

Drugs

lidocaine
03

Conditions

coughPost-extubation sore throat (POST)

Beyond the preview

Go deeper on TCTR20200325003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200325003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call